Nextleaf Solutions

Providing Patented Cannabis Extraction Processing Services

This Nextleaf Solutions Ltd. profile is part of a paid investor education campaign.*


Nextleaf Solutions Ltd. (CSE:OILS,OTCQB:OILFF,FWB:L0MA) is developing disruptive intellectual property for industrial-scale extraction, purification and formulation of cannabinoids. Nextleaf owns a portfolio of eight issued and over 30 pending patents pertaining to the production of high-purity, cannabinoid-rich distillate, the key ingredient used in the manufacturing of standardized THC and CBD-infused products. Once cannabis concentrates and edibles become legal across Canada, Nextleaf plans to commercialize its intellectual property portfolio through IP licensing and B2B processing services.

Projects and Products

Since its inception, Nextleaf has been focused on developing and protecting intellectual property on methods and hardware for the industrial-scale extraction, purification and refinement of cannabinoids. The company is also developing formulations and technology that enables the novel production of cannabinoid-infused products. Nextleaf continues to innovate and grow its existing patent portfolio of 40 patents, of which eight are granted and 32 are pending.

Through an agreement with Nextleaf Labs Ltd., Nextleaf is commercializing its core extraction technology at its licensed facility which is capable of processing more than 270,000 kilograms of dried cannabis biomass per year using Nextleaf Solution Ltd.’s patented, custom chilled ethanol-based extraction and purification system. The patented process and equipment yields a tasteless, odorless cannabis concentrate that can be manufactured at scale, standardized for dose, and ready for infusion in premium value-add products.

Nextleaf Solutions’ Company Highlights:

  • First public company granted a patent for the industrial-scale extraction, refinement and purification of cannabinoids.
  • Intellectual property portfolio consisting of 40 patents, including eight granted and 32 pending.
  • Intellectual property encompasses the end-to-end process, as well as proprietary pieces of equipment used for the refinement of crude extract and the formulation of purified THC and CBD distillate.
  • Nextleaf has an exclusive technology licensing agreement with BevCanna Enterprises Inc. (CSE:BEV), who utilizes the technology to manufacture a range of cannabinoid-infused beverages in their BC bottling facility with an annual capacity of over 30-million bottled beverages. Nextleaf is expected to supply cannabinoids to BevCanna under the agreement.
  • Centralized extraction processing facility, located in Greater Vancouver. 6,540-square-foot facility with Phase 1 capacity to process more than 270,000 kilograms per year of cannabis biomass to high purity distillate.
  • National Research Council Grant through the Industrial Research Assistance Program (IRAP) for the development of unique processing techniques for removing chlorophyll and other impurities from crude oil extracts.
  • Sustainable Development Technology Canada (SDTC) $2.5 million consortium with Terramera for replacing toxic chemical pesticides with pesticides derived from natural products.
  • Natural Science & Engineering Research Council (NSERC) partnership with the University of British Columbia (UBC) and British Columbia Institute of Technology (BCIT), for the development of methods pertaining to repurposing incinerated cannabis waste biomass for industrial construction.

Nextleaf Solutions’ Management Team

Paul Pedersen, MBA Co-Founder, CEO and Director

Paul has been focused on the cannabis industry since 2013, consulting for a variety of cannabis companies and investors, including Canada’s first cannabis oil producer and leading seed-to-sale software provider. Paul holds an MBA (finance) from Michigan State. Founder of NASDAQ: TWER.

Charles Ackerman, CPA, CA CFO and Director

Charles has been in the cannabis industry since 2015 having worked with Canada’s first licensed commercial producer. He has successfully assisted a number of companies in transition from private to public markets, develop and execute growth strategies, with private and public companies and family offices across Canada. Charles holds a Chartered Professional Accountant designation.

Ryan Ko Co-Founder and CTO

Ryan has been in the cannabis industry for over 15-years. In that time he has developed deep expertise and intellectual property within extraction technology, leading to one of Canada’s first patents for cannabis extraction and distillation. Ryan is one of the early innovators of the legal medical cannabis program in Canada.

Tim Gillis, CPA, CA Non-Executive Director

Tim is an experienced leader in the healthcare and pharmaceutical technology sectors. He is the former CEO of STI Technologies (“STI”). Tim steered STI through a period of dramatic growth, which culminated in the sale of the business to IQVIA (NYSE: IQV) in 2017. Throughout his career, which includes senior roles with Stantec (TSX: STN) and Clarke (TSX: CKI) he has completed over $345MM in mergers and acquisitions.

*Disclaimer: This profile is sponsored by Nextleaf Solutions (CSE:OILS). This company profile provides information which was sourced by the Investing News Network (INN) and approved by Nextleaf Solutions, in order to help investors learn more about the company. Nextleaf Solutions is a client of INN. The company’s campaign fees pay for INN to create and update this profile.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Nextleaf Solutions and seek advice from a qualified investment advisor.